Drug Type mRNA vaccine |
Synonyms mRNA 4203, mRNA4203 |
Target |
Action inhibitors |
Mechanism PRAME inhibitors(PRAME nuclear receptor transcriptional regulator inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Melanoma, Cutaneous Malignant | Phase 1 | United States | 25 Jul 2025 | |
| Synovial Sarcoma | Phase 1 | United States | 25 Jul 2025 | |
| Unresectable Melanoma | Phase 1 | United States | 25 Jul 2025 |





